Cann to supply additional cannabis flower products to Levin Health
Cann Group Limited is pleased to announce that it has varied the agreement announced on 20 June 2023, with Levin Health Pty Ltd.
The most recent variation will now see Cann supply, and Levin commit to purchasing, additional flower products to meet Levin’s production schedule to the value of approximately $1.58 million from 1 September 2023 – 31 December 2023.
Cann will supply a total of $2.29 million in flower products to Levin for the period 1 July 2023 to 31 December 2023. Cann will also supply oil products to the value of $0.85 million under the agreement to 31 December 2023.
Cann CEO Peter Koetsier said, “Cann Group is proud to partner with Levin Health and to extend our agreement, which represents a key platform for strong success for both companies.
“Securing longer-term supply agreements with our preferred partners is a critical component of the Cann Group strategy for the future.
“Cann recognises the importance of establishing stable and reliable supply chains using our TGO 93 compliant cultivation and production facility to meet the evolving demands of our customers.
“Through this, we believe we can enhance our competitive advantage and position ourselves as a trusted and dependable partner in the industry.”